Drug Discovery Digital 2020 - Connect - Learn - Discover

Overview


Welcome to Drug Discovery Digital

Due to the restrictions imposed by the global COVID-19 pandemic, ELRIG’s flagship conference Drug Discovery, now in its 14th year, will be a virtual event.

Taking place over a 2 week period from 6 – 16 October 2020, you can now enjoy the usual world-class science and exhibition you would expect from our flagship conference but from the comfort of your own desktop to fit with your daily schedule!

As with every year, however, Drug Discovery Digital will still include cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 50 world-class speakers with 8 main session tracks and 2 plenary keynote speakers. The tracks for 2020 are:

Better Hits = Better therapeutics?
Innovations in Chemistry to discover new medicines
GPCRs in drug discovery hosted by the British Pharmacological Society
Addressing the challenges of Infection – how do we develop new treatments?
Patient relevant models for drug discovery
Multi Omic approaches to deliver new medicines
Cancer Research UK track
New Modalities to treat disease

Drug Discovery has become the largest meeting of life sciences industry professionals in the UK and we plan on making this the largest virtual drug discovery event in the UK .

This event will bring together delegates and exhibiting companies from around the world in a virtual conference that will highlight the latest ground-breaking research, discuss cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs.

Plenary Keynote Speakers

Darrin Disley (Mogrify)
Professor Sarah J Tabrizi (UCL)

We have several sponsorship opportunities available to our vendors that can provide a wide range of new and exciting benefits for your organisation. We are also happy to discuss a tailored package to suit your budget.


Venue: Web Event
Organiser Contact Details:
ELRIG UK

T: 07484 113971
info@elrig.org

Delegates Registration


Download Download
Andrews
Dr David Andrews
Director of Pre-clinical Scientific Alliances
AstraZeneca
Speaker
Blakey
Dr David Blakey
Chief Scientific Officer
MiNA Therapeutics
Speaker
Chung
Dr Chun-wa Chung
UK Director of Structural and Biophysical Sciences
GSK R&D
Speaker
Creighton-Gutteridge
Mark Creighton-Gutteridge
GlaxoSmithKline
Speaker
Dawson
Dr Michael Dawson
Director
Mike Dawson Antimicrobial Research Consultancy Ltd.
Speaker
Disley OBE
Dr Darrin M Disley OBE
Chief Executive Officer
Mogrify Limited
Speaker
Drewes
Dr Gerard Drewes
Global Head, Genome Editing Technologies
GlaxoSmithKline
Speaker
Kendall
Prof David Kendall
CSO
PharmNovo
Speaker
Kendrew
Mrs Jane Kendrew
Director of Translational Oncology
Sygnature Discovery
Speaker
Kettleborough
Catherine Kettleborough
LifeArc
Speaker
Leveridge
Melanie Leveridge
GlaxoSmithKline
Speaker
Lundbäck
Dr Thomas Lundbäck
Associate Director
Discovery Sciences, AstraZeneca
Speaker
Marston
Dr Fiona Marston
Director
LSTM
Speaker
Merritt
Dr Andy Merritt
Head of Chemistry
LifeArc
Speaker
Nickolls
Dr Sarah Nickolls
Group leader
GlaxoSmithKline
Speaker
Nurmi
Dr Antti Nurmi
Managing Director
Charles River Discovery Services Finland
Speaker
Rolando
Delphine Rolando
Benevolent
Speaker
Tabrizi
Prof Sarah Tabrizi
UCL
Speaker
Waddell
Ian Waddell
Charles River Laboratories
Speaker
Young
Dr Steve Young
VP Business Development
Sygnature Discovery
Speaker

Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020